Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Spring Bank Pharmaceuticals- Inc. (SBPH)

12.56 0.12 (0.96%)

07-20 16:00

Open:

12.42

Pre. Close:

12.44

High:

12.7999

Low:

12.42

Volume:

12,956

Market Cap:

166M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

12.801 - 12.846

12.846 - 12.887

Low:

12.292 - 12.349

12.349 - 12.402

Close:

12.47 - 12.549

12.549 - 12.622

Technical analysis  (as of: 2018-07-20 4:42:07 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 15.19     One year: 16.70

Support:

Support1: 10.92    Support2: 9.09

Resistance:

Resistance1: 13.01    Resistance2: 14.30

Pivot:

12.07

Moving Averages:

MA(5): 12.15     MA(20): 12.12

MA(100): 13.86     MA(250): 13.88

MACD:

MACD(12,26): -0.26     Signal(12,26,9): -0.37

%K %D:

%K(14,3): 59.61     %D(3): 47.74

RSI:

RSI(14): 50.59

52-Week:

High: 18.93  Low: 10.81  Change(%): -10.0

Average Vol(K):

3-Month: 4923  10-Days 5169

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
SBPH has closed below upper band by 13.1%. Bollinger Bands are 34.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-02-20T16:54:54-05:00
Spring Bank Pharma reports Q4 results

2017-11-16T14:35:00-05:00
Your Daily Pharma Scoop: A Look At Sanofi, Ultragenyx Gets FDA Nod, Capricor Tumbles

2017-11-15T16:58:23-05:00
Spring Bank Pharma's inarigivir shows positive effect in mid-stage HBV study

2017-11-06T15:45:35-05:00
Biotech Forum Daily Digest: Why Adamas Is Soaring

2017-11-06T09:21:40-05:00
Analyst action - healthcare

2017-10-27T06:00:00-04:00
ROTY Volume 1 Edition 43: Thoughts On The Biotech Sector, Conserving Cash And New Trades

2017-10-24T10:03:32-04:00
ROTY Volume 1 Edition 42: Thoughts On Underpeformers And New Trades

2017-10-11T13:50:53-04:00
A Current Breakdown Of The ROTY Model Account

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

13.17

Shares Float (M)

12.00

% Held by Insiders

9.00

% Held by Institutions

32.50

Shares Short (K)

228

Shares Short Prior Month (K)

Stock Financials

EPS

-1.860

EPS Est. Current Year

-2.540

EPS Est. Next Year

-2.260

EPS Est. Next Quarter

-0.510

Forward EPS

-2.750

Book Value (p.s.)

4.780

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-73.0

Return on Equity (ttm)

-117.4

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.262

Qtrly Earnings Growth

Operating Cash Flow (M)

-19.76

Levered Free Cash Flow (M)

-11.73

atoplab.com

Valuation

P/E

-6.75

P/E Growth Ratio

0.01

P/BV

2.63

P/S

P/CF

-8.37

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.